Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine Life Science
Healthcare Roundup – J&J’s daratumumab extends survival in first-line multiple myeloma, Death reported in Brazil study of AstraZeneca COVID-19 vaccine Life Science
Technology Roundup – Chinese tech firms flag concerns about Nvidia’s Arm deal, Jack Ma’s Ant Group gets Chinese approval for Shanghai arm of $35B IPO Technology
Healthcare Roundup – CytoDyn study of leronlimab for COVID-19 passes first interim tollgate, Novavax to present COVID-19 vaccine data Life Science
Technology Roundup – Google shares rise amid landmark U.S. antitrust suit, Adobe launches Illustrator for iPad Technology
Healthcare Roundup – CVS looks to hire another 15,000 employees, Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets Life Science
Technology Roundup – Intel sells storage unit to SK Hynix in $9B deal, IBM slips after third consecutive revenue decline Technology
Healthcare Roundup – Sinovac’s COVID-19 vaccine offered by Chinese city for emergency use, CytoDyn to discuss DSMC’s review of interim analysis in COVID-19 Life Science
Technology Roundup – Ant Group’s IPO valuation increases again to $280B, China set to approve its own tech protection law Technology
Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir Life Science
Technology Roundup – FCC Chairman Pai says he’ll revisit social-media law, Big Tech sentiment gets shaky Technology
Boosted by Hong Kong Capital, will TAAT’s stock take off? | Taat Lifestyle & Wellness Ltd. Consumer Goods, Life Science
Technology Roundup – Apple’s iPhone 12 suppliers positively mentioned at JPMorgan, Carriers look to solidify customer base with iPhone deals Technology
Healthcare Roundup – Trump administration expands collaboration with AstraZeneca on COVID-19 antibody drug, Moderna makes headway in bringing COVID vaccine to European market Life Science
